| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 52276-312-60 | 52276-312 | HUMAN PRESCRIPTION DRUG | Carbaglu | Carglumic Acid | TABLET, FOR SUSPENSION | ORAL | 20100318 | N/A | NDA | NDA022562 | Recordati Rare Diseases | CARGLUMIC ACID | 200 mg/1 | 60 TABLET, FOR SUSPENSION in 1 BOTTLE (52276-312-60) |
| 52276-312-05 | 52276-312 | HUMAN PRESCRIPTION DRUG | Carbaglu | Carglumic Acid | TABLET, FOR SUSPENSION | ORAL | 20100318 | N/A | NDA | NDA022562 | Recordati Rare Diseases | CARGLUMIC ACID | 200 mg/1 | 5 TABLET, FOR SUSPENSION in 1 BOTTLE (52276-312-05) |